ArticleJournal of translational medicine2026
MTHFD2 modulates neural stem cell proliferation and apoptosis after intracerebral hemorrhage by regulating mitochondrial NADPH homeostasis.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundIntracerebral hemorrhage (ICH) represents one of the most severe forms of cerebrovascular injury, characterized by high mortality and lasting neurological dysfunction. Neural stem cells (NSCs), which are indispensable for neurogenesis, are mainly distributed in the hippocampus, a brain region essential for learning and memory. However, alterations in hippocampal NSCs following ICH and the mechanisms that mediate these changes remain poorly defined. The present study investigates the effects of ICH on hippocampal NSCs, focusing on the regulatory role of MTHFD2 in maintaining mitochondrial redox homeostasis through NADPH metabolism.
methodsBoth in vivo and in vitro ICH models were used, including a collagenase-induced mouse model and a hemin-treated NSC model, to examine molecular and cellular responses of hippocampal NSCs to hemorrhagic injury. Western blotting, RNA sequencing, CUT&Tag profiling, and ChIP-qPCR were employed to analyze the related pathways.
resultsWe found that NSCs exhibited a time-dependent response after ICH, showing initial activation followed by gradual functional exhaustion and increased apoptosis. ICH induced persistent endoplasmic reticulum stress and significantly upregulated MTHFD2, a mitochondrial enzyme essential for one-carbon metabolism. Mechanistically, MTHFD2 was required to maintain mitochondrial integrity and redox homeostasis by regulating NADPH levels. Knockdown of MTHFD2 reduced NSC proliferation, increased apoptosis, and worsened cognitive impairment in ICH mice. Exogenous NADPH supplementation partially restored these changes, emphasizing the importance of redox balance in NSC survival and function.
conclusionsOur findings identify MTHFD2 as a key metabolic regulator supporting NSC adaptation to ICH through NADPH-dependent mitochondrial mechanisms. Targeting mitochondrial redox metabolism may provide a potential strategy for preserving NSC function and improving cognitive recovery after ICH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.